Finance

Lists
XGN:NASDAQ
Exagen Inc
8,28 US$
-1,71%
(-0,14) 1D
12 ოქტ, 11:46:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XGN...
Open
8,20 US$
High
8,49 US$
Low
8,20 US$
Mkt. cap
200,49 მლნ.
Avg. vol.
281,76 ათ.
Volume
52,78 ათ.
52-wk high
12,23 US$
52-wk low
2,60 US$
EPS
-0,81 US$
Beta
2,12
Shares outstanding
24,22 მლნ.
No. of employees
218
Open
8,20 US$
High
8,49 US$
Low
8,20 US$
Mkt. cap
200,49 მლნ.
Avg. vol.
281,76 ათ.
Volume
52,78 ათ.
52-wk high
12,23 US$
52-wk low
2,60 US$
EPS
-0,81 US$
Beta
2,12
Shares outstanding
24,22 მლნ.
No. of employees
218
News stories
From web sources and news partners
About Exagen Inc
CEO-
Employees218
Founded2002
HeadquartersVista, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websiteexagen.com
Analyst ratings
Based on 5 analysts giving stock ratings to XGN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for XGN in the last 3 months.
Highest
Current 8,28 US$
12,00 US$ (+45,00%)
Average
10,20 US$ (+23,25%)
Lowest
9,00 US$ (+8,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Maintained
11,00 US$
+32,9%
09/22/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
12,00 US$
+45%
09/11/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
12,00 US$
+45%
08/05/2026
Mark Massaro
BTIG
Buy
Reiterated
9,00 US$
+8,7%
08/05/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
9,00 US$
+8,7%
08/05/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
10,00 US$
+20,8%
08/04/2026
Unknown Analyst
Roth MKM
Buy
Initiated
8,00 US$
-3,3%
06/24/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
05/12/2026
William Bonello
Craig-Hallum
Buy
Reiterated
10,00 US$
+20,8%
03/11/2026
Paul Knight
KeyBanc
Buy
Maintained
10,00 US$
+20,8%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
17,24 მლნ.
16,63 მლნ.
17,31 მლნ.
19,94 მლნ.
Cost of goods sold
7,17 მლნ.
7,42 მლნ.
7,10 მლნ.
7,72 მლნ.
Cost of revenue
7,17 მლნ.
7,42 მლნ.
7,10 მლნ.
7,72 მლნ.
Research and development expenses
1,73 მლნ.
1,76 მლნ.
1,55 მლნ.
1,43 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,44 მლნ.
12,42 მლნ.
12,07 მლნ.
12,51 მლნ.
Operating expense
13,18 მლნ.
14,18 მლნ.
13,62 მლნ.
13,94 მლნ.
Total operating expenses
20,34 მლნ.
21,61 მლნ.
20,72 მლნ.
21,66 მლნ.
Operating income
-3,10 მლნ.
-4,98 მლნ.
-3,41 მლნ.
-1,72 მლნ.
Other non operating income
-
-
-132,00 ათ.
153,00 ათ.
EBT including unusual items
-7,09 მლნ.
-4,66 მლნ.
-3,93 მლნ.
-3,20 მლნ.
EBT excluding unusual items
-4,42 მლნ.
-6,26 მლნ.
-4,81 მლნ.
-2,77 მლნ.
Income tax expense
1,00 ათ.
13,00 ათ.
36,00 ათ.
-
Effective tax rate
-0,01%
-0,28%
-0,92%
-
Other operating expenses
-
-
-
-
Net income
-7,09 მლნ.
-4,67 მლნ.
-3,97 მლნ.
-3,20 მლნ.
Net profit margin
-41,10%
-28,10%
-22,92%
-16,03%
Earnings per share
-0,31
-0,27
-0,20
-0,11
Interest and investment income
3,00 ათ.
43,00 ათ.
-
-
Interest expense
-1,32 მლნ.
-1,33 მლნ.
-1,27 მლნ.
-1,20 მლნ.
Net interest expenses
-1,32 მლნ.
-1,29 მლნ.
-1,27 მლნ.
-1,20 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,49 მლნ.
-4,38 მლნ.
-2,82 მლნ.
-1,09 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები